BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 24211319)

  • 21. Pegfilgrastim compared with filgrastim for cytokine-alone mobilization of autologous haematopoietic stem and progenitor cells.
    Herbert KE; Gambell P; Link EK; Mouminoglu A; Wall DM; Harrison SJ; Ritchie DS; Seymour JF; Prince HM
    Bone Marrow Transplant; 2013 Mar; 48(3):351-6. PubMed ID: 22858510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Kroschinsky F; Hölig K; Platzbecker U; Poppe-Thiede K; Ordemann R; Blechschmidt M; Oelschlaegel U; Schaich M; Hänel M; Bornhäuser M; Ehninger G
    Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized trial of two popular mononuclear cell collection sets for autologous peripheral blood stem cell collection in multiple myeloma.
    Cooling L; Hoffmann S; Herrst M; Muck C; Armelagos H; Davenport R
    Transfusion; 2010 Jan; 50(1):100-19. PubMed ID: 19719472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
    Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
    Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study.
    de la Rubia J; Bladé J; Lahuerta JJ; Ribera JM; Martínez R; Alegre A; García-Laraña J; Fernández P; Sureda A; de Arriba F; Carrera D; Besalduch J; García Boyero R; Palomera Bernal L; Hernández MT; García PR; Pérez-Calvo J; Alcalá A; Casado LF; San Miguel J
    Haematologica; 2006 May; 91(5):621-7. PubMed ID: 16627253
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patients mobilizing large numbers of CD34+ cells ('super mobilizers') have improved survival in autologous stem cell transplantation for lymphoid malignancies.
    Bolwell BJ; Pohlman B; Rybicki L; Sobecks R; Dean R; Curtis J; Andresen S; Koo A; Mineff V; Kalaycio M; Sweetenham JW
    Bone Marrow Transplant; 2007 Sep; 40(5):437-41. PubMed ID: 17618321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CXCR4 expression on transplanted peripheral blood CD34+ cells: relationship to engraftment after autologous transplantation in a cohort of multiple myeloma patients.
    Hicks C; Isaacs A; Wong R; Chong BH
    Ann Hematol; 2011 May; 90(5):547-55. PubMed ID: 20957366
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow up of sequential mobilisation and autologous transplantation with CD34-selected cells in multiple myeloma: a multimodality approach.
    Horvath N; Hahn U; Joshua D; Dyson P; Gibson J; Stevens J; Rawling T; Barrow L; Brown R; Stephens S; Gower G; Norman J; Mills B; To LB
    Intern Med J; 2004 Apr; 34(4):167-75. PubMed ID: 15086696
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of different strategies of second-line stem cell harvest on the outcome of autologous transplantation in poor peripheral blood stem cell mobilizers.
    Goterris R; Hernández-Boluda JC; Teruel A; Gómez C; Lis MJ; Terol MJ; Tormo M; Solano C; Arbona C
    Bone Marrow Transplant; 2005 Nov; 36(10):847-53. PubMed ID: 16113660
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful mobilization of peripheral blood stem cells after addition of ancestim (stem cell factor) in patients who had failed a prior mobilization with filgrastim (granulocyte colony-stimulating factor) alone or with chemotherapy plus filgrastim.
    To LB; Bashford J; Durrant S; MacMillan J; Schwarer AP; Prince HM; Gibson J; Lewis I; Swart B; Marty J; Rawling T; Ashman L; Charles S; Cohen B
    Bone Marrow Transplant; 2003 Mar; 31(5):371-8. PubMed ID: 12634728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation.
    Uy GL; Costa LJ; Hari PN; Zhang MJ; Huang JX; Anderson KC; Bredeson CN; Callander NS; Cornell RF; Perez MA; Dispenzieri A; Freytes CO; Gale RP; Garfall A; Gertz MA; Gibson J; Hamadani M; Lazarus HM; Kalaycio ME; Kamble RT; Kharfan-Dabaja MA; Krishnan AY; Kumar SK; Kyle RA; Landau HJ; Lee CH; Maiolino A; Marks DI; Mark TM; Munker R; Nishihori T; Olsson RF; Ramanathan M; Rodriguez TE; Saad AA; Savani BN; Schiller GJ; Schouten HC; Schriber JR; Scott E; Seo S; Sharma M; Ganguly S; Stadtmauer EA; Tay J; To LB; Vesole DH; Vogl DT; Wagner JL; Wirk B; Wood WA; D'Souza A
    Bone Marrow Transplant; 2015 Dec; 50(12):1513-8. PubMed ID: 26301967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.
    Olivieri J; Attolico I; Nuccorini R; Pascale SP; Chiarucci M; Poiani M; Corradini P; Farina L; Gaidano G; Nassi L; Sica S; Piccirillo N; Pioltelli PE; Martino M; Moscato T; Pini M; Zallio F; Ciceri F; Marktel S; Mengarelli A; Musto P; Capria S; Merli F; Codeluppi K; Mele G; Lanza F; Specchia G; Pastore D; Milone G; Saraceni F; Di Nardo E; Perseghin P; Olivieri A
    Bone Marrow Transplant; 2018 Apr; 53(4):461-473. PubMed ID: 29330395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictive factors for stem cell mobilization failure in multiple myeloma patients: A single center experience.
    Goker H; Ciftciler R; Demiroglu H; Turgut M; Sayınalp N; Haznedaroglu IC; Okay M; Tekin F; Buyukasık Y
    Transfus Apher Sci; 2020 Feb; 59(1):102595. PubMed ID: 31492570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Outcomes of poor peripheral blood stem cell mobilizers with multiple myeloma at the first mobilization: A multicenter retrospective study in Japan.
    Miyamoto-Nagai Y; Mimura N; Tsukada N; Aotsuka N; Ri M; Katsuoka Y; Wakayama T; Suzuki R; Harazaki Y; Matsumoto M; Kumagai K; Miyake T; Ozaki S; Shono K; Tanaka H; Shimura A; Kuroda Y; Sunami K; Suzuki K; Yamashita T; Shimizu K; Murakami H; Abe M; Nakaseko C; Sakaida E
    EJHaem; 2022 Aug; 3(3):838-848. PubMed ID: 36051061
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor hematopoietic stem cell mobilizers in multiple myeloma: a single institution experience.
    Ruiz-Delgado GJ; López-Otero A; Hernandez-Arizpe A; Ramirez-Medina A; Ruiz-Argüelles GJ
    Mediterr J Hematol Infect Dis; 2010 Jun; 2(2):e2010016. PubMed ID: 21415967
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk Factors and Outcomes of Stem Cell Mobilization Failure in Multiple Myeloma Patients.
    Hsu TL; Tsai CK; Liu CY; Yeh CM; Lin FL; Hsiao LT; Liu YC; Wang HY; Ko PS; Lin TA; Chen WC; Chen PM; Liu JH; Gau JP; Liu CJ
    Transfus Med Hemother; 2023 Feb; 50(1):39-50. PubMed ID: 36818774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mobilization policy in multiple myeloma: minimum target or law of redundancy? Two different approaches by the two sides of the Atlantic Ocean.
    Olivieri A; Saraceni F
    Bone Marrow Transplant; 2016 Mar; 51(3):348-50. PubMed ID: 26691418
    [No Abstract]   [Full Text] [Related]  

  • 38. Successful mobilization of PBSCs predicts favorable outcomes in multiple myeloma patients treated with novel agents and autologous transplantation.
    Brioli A; Perrone G; Patriarca F; Pezzi A; Nobile F; Ballerini F; Motta MR; Ronconi S; Tacchetti P; Catalano L; Zannetti BA; Rizzi S; Volpe S; Zamagni E; Liberati AM; Mancuso K; Boccadoro M; Davies FE; Morgan GJ; Palumbo A; Cavo M
    Bone Marrow Transplant; 2015 May; 50(5):673-8. PubMed ID: 25642764
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing stem cell mobilization: lessons learned.
    Becker PS
    J Natl Compr Canc Netw; 2014 Oct; 12(10):1443-9. PubMed ID: 25313183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma.
    Tuchman SA; Bacon WA; Huang LW; Long G; Rizzieri D; Horwitz M; Chute JP; Sullivan K; Morris Engemann A; Yopp A; Li Z; Corbet K; Chao N; Gasparetto C
    J Clin Apher; 2015 Jun; 30(3):176-82. PubMed ID: 25293363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.